Navigation Links
National Association Endorses Recommendations for Contrast Agent Use in Heart Ultrasounds (Echocardiograms)
Date:11/4/2008

American Society of Echocardiography Lays out Clinical Applications and Safety Considerations

MORRISVILLE, N.C., Nov. 4 /PRNewswire/ -- The American Society of Echocardiography (ASE) today backed the use of contrast agents, used to enhance echocardiogram images, and provided a guide for physicians who may be hesitant to use the contrast agents following a 2007 Food and Drug Administration (FDA) black box warning. In a new statement, supported by expert consensus opinion, critical review, and evidence-based research, ASE outlines why, when and how the contrast agents should be used to enhance diagnosis, the role for each person in the lab, and methods to implement contrast in the lab. The statement, "The American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography," was released in the November 2008 issue of The Journal of the American Society of Echocardiography.

Cardiologists use echocardiograms (live, real-time ultrasound images of the beating heart) to evaluate the heart's performance, as well as the structures of the heart. The consensus statement affirms that contrast enhancement is an essential part of modern, quality-driven echocardiography laboratories inside and outside the hospital where both resting and stress echo testing are done.

"Ultrasound contrast agents have an established role in clinical diagnosis, patient management and clinical research," said Dr. Sharon Mulvagh, one of the lead authors of the document. "Contrast agents can provide sonographers and physicians the clear images they need to diagnose life threatening heart conditions that may not be otherwise visible."

Acknowledging that the FDA black box warning initiated in 2007 and revised in 2008 may weigh heavily on concerned physicians, ASE outlined the proven benefits of contrast agents in its consensus statement, and reviewed the specific contraindications which include significant intracardiac shunts, and known hypersensitivity. Beyond the obvious benefits of being able to clearly see heart structures in patients with poor images, most commonly due to intervening fat and lung tissues, unique benefits include the following:

-- Contrast enhanced echocardiography in the emergency department can play

a useful role in the triage of patients with chest pain through

accurate, early diagnosis.

-- Contrast enhancement in technically difficult to image patients in the

intensive care unit (ICU) can be used to provide bedside assessment of

cardiac structure and function without having to resort to more invasive

procedures (such as placing a probe into the esophagus and stomach).

-- The accuracy of contrast echocardiography has been validated for the

qualitative and quantitative assessment of the heart chambers and should

be considered in patients in whom precise information is clinically

required - such as patients under consideration for medical devices or

potential heart transplant.

"Those in the medical field concerned about the safety of ultrasound contrast agents should consider the proven efficacy, the previously established safety of these compounds, and the potential risk of alternative procedures," said Dr. William A. Zoghbi, President of the American Society of Echocardiography. "Ultrasound contrast agents have been safely and effectively used in echocardiography studies performed in the echo lab, emergency department, ICU, interventional cardiology suite, and operating room."

ASE also noted that contrast agent use is cost-effective when used in an appropriate and efficient manner. Contrast echocardiography can convert a technically difficult, nondiagnostic stress echocardiogram into an accurate diagnostic study and avoid either an unachievable, missed or wrong diagnosis. This obviates the need for putting the patient through further testing and improves efficiency, resulting in cost savings.

ASE advises the medical community that implementation of a contrast program requires a strong commitment to quality on the part of the medical director. Laboratories that have been successful in establishing contrast agent use have uniformly implemented a practice by which the sonographer, at the beginning of the study, identifies the need for the use of a contrast agent, on the basis of a standing order that clearly describes appropriate indications and addresses the relatively few contraindications.

To read the full document, visit http://www.asecho.org.

About ASE

The American Society of Echocardiography (ASE) is a professional organization of physicians, cardiac sonographers, nurses and scientists involved in echocardiography, the use of ultrasound to image the heart and cardiovascular system. The organization was founded in 1975 and has more than 14,000 members nationally and internationally. For more information on ASE, visit http://www.asecho.org or ASE's Public Information site, http://www.SeeMyHeart.org.

Contact: Katy Funk

katyf@imrecommunications.com

410-821-8220


'/>"/>
SOURCE The American Society of Echocardiography
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , ... March 27, 2017 , ... ... for clear braces. People who want straight teeth without the extensive time commitment ... in Clearwater, FL, without acquiring a referral. A custom-designed series of virtually invisible ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... for custom smile makeovers without requiring a referral. Trimble Dental offers ... disease treatment, cosmetic dentistry and dental implants. Whether patients have discolored, crooked or ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who want to ... missing teeth can now have them placed by Dr. Manju Kejriwal, with or without ... Beam technology to increase the accuracy of each dental implant placement. The i-CAT CBCT ...
(Date:3/27/2017)... ... ... Drs. Justin Kolnick, Kara Diamond, Randall Barton, Keith Hope and Bilal Chaudhry ... this treatment plays in protecting oral health, along with the benefits of receiving ... a root canal in White Plains, NY or their second location in Mt. Kisco, ...
(Date:3/27/2017)... ... March 27, 2017 , ... Biotechnology and ... and engagement over the household brands of Top-20 pharma by optimizing clinical trial ... partnering with the right outsourcing payments provider can provide the technology, infrastructure, and ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Summary This report provides all the information ... and activities since 2010. Description The Partnering Deals and ... partnering activity of one of the world,s leading life sciences ... purchase to ensure inclusion of the most up to date ... delivered in PDF format within 1 working day of receipt ...
(Date:3/27/2017)... , March 27, 2017 ... better understand Eli Lilly and its partnering interests and activities ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ... company data. The report will be delivered in ...
(Date:3/27/2017)... , March 27, 2017 ... specialty clinical-stage pharmaceutical company specializing in the development of ... public offering in the United States ... each ADS representing 40 ordinary shares of the ... In addition, Therapix has granted the underwriters a ...
Breaking Medicine Technology: